Fluoresence-based Detection
A novel platform for screening drug-resistant mutations
DR.sTraTeGY -- Drug Resistance mutation Tracking Technology based on Grape Yeast
A platform could accelerate antifungal drug development,
deepen our understanding of evolution,
and assist humanity’s defense against fungal threats
A novel platform for screening drug-resistant mutations
Utilizing engineered grape yeast as a versatile and efficient chassis
An integrated model for predicting multicellular behaviors
DR.sTraTeGY provides a rapid, low-cost chassis to validate mutations and drug effects, offering great potential to accelerate new drug discovery and screening.
Through programmable environments researchers can directly observe evolutionary divergences, deepening humanity’s understanding of the universal principles of life’s evolution.
The application of DR.sTraTeGY implies that humanity can fortify defenses ahead of a full-scale outbreak of drug resistance, establishing a societal safeguard against superfungi.
By making abstract genetic mutations and evolutionary processes “visual” through colors and different morphologies, it can advance public science education and foster social consensus.
in finding new strategies to wage the war against antimicrobial resistance.